US Patent Issued to THE BRIGHAM AND WOMEN'S HOSPITAL, ACCELERON PHARMA on July 14 for "Methods for treating pulmonary disease with a ligand binding domain of a TGF-Beta type II receptor" (Massachusetts Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,483, issued on July 14, was assigned to THE BRIGHAM AND WOMEN'S HOSPITAL INC. (Boston) and ACCELERON PHARMA INC. (Cambridge, Mass.).

"Methods for treating pulmonary disease with a ligand binding domain of a TGF-Beta type II receptor" was invented by Paul B. Yu (Boston), Asya Grinberg (Lexington, Mass.), Dianne S. Sako (Medford, Mass.), Roselyne Castonguay (Malden, Mass.), Rita Steeves (Stoneham, Mass.) and Ravindra Kumar (Acton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In some aspects, the invention teaches pharmaceutical compositions that include a TGF-Beta ligand trap, and methods of using a TGF-Beta ligand trap to treat, prevent, or r...